Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
Status: | Completed |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease, Endocrine, Diabetes |
Therapuetic Areas: | Endocrinology, Nephrology / Urology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 3/3/2019 |
Start Date: | February 13, 2017 |
End Date: | November 25, 2018 |
This pilot study tests the feasibility of dietary app-supported tele-counseling in the
treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
Patients with diabetes and stage 1-3a CKD receive instructions on downloading and using
MyFitnessPal on their smartphone or computer to log meal data daily, weekly website
educational materials, and weekly telephone visits with a dietician for 8 weeks. Patients
receive a follow-up phone call from the dietitian and 5 and 11 months for further support and
counseling, and are also invited to attend a local dietitian-led grocery tour. This pilot
study examines the feasibility of dietary app-supported tele-counseling in the treatment of
patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
Main outcomes include sodium intake assessed by 24 hour urine collection as well as other
dietary measures related to kidney disease (sodium/potassium ratio, Healthy Eating Index
score, 24-hour urine phosphorus, estimated net endogenous acid production) and health
measures (24-hour ambulatory blood pressure, weight, albumin/creatinine ratio)
MyFitnessPal on their smartphone or computer to log meal data daily, weekly website
educational materials, and weekly telephone visits with a dietician for 8 weeks. Patients
receive a follow-up phone call from the dietitian and 5 and 11 months for further support and
counseling, and are also invited to attend a local dietitian-led grocery tour. This pilot
study examines the feasibility of dietary app-supported tele-counseling in the treatment of
patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
Main outcomes include sodium intake assessed by 24 hour urine collection as well as other
dietary measures related to kidney disease (sodium/potassium ratio, Healthy Eating Index
score, 24-hour urine phosphorus, estimated net endogenous acid production) and health
measures (24-hour ambulatory blood pressure, weight, albumin/creatinine ratio)
Inclusion Criteria:
- Age > 21 years
- Diabetes diagnosis (Type I or Type II)
- Last urine albumin/creatinine ratio (ACR) within the past two years > 30 mg/g
- Last outpatient estimated glomerular filtration rate (eGFR) within the past year > 45
ml/min/1.73m2
- Last outpatient systolic blood pressure (SBP) within the past year < 160 mmHg
- Last outpatient diastolic blood pressure (DBP) within the past year <100 mmHg
- Preceding eGFR decline rate less than -2 ml/min/1.73m2/y
- At least 2 outpatient eGFR measurements in electronic health record, separated by at
least 2 years
- Agreeable to change diet (decrease sodium and red/processed meat intake, increase
fruit and vegetable intake)
- Access to smartphone or computer
Exclusion Criteria:
- Inability to understand English
- Myocardial infarction, stroke, or atherosclerotic cardiovascular disease procedure
within 6 months.
- Current treatment for malignancy
- Planned bariatric surgery
- Pregnancy or planning to become pregnant within next 2 years
- Self-reported average consumption of > 14 alcoholic beverages per week
- Psychiatric hospitalization in past year
- Unstable angina
- Urine ACR > 2500 mg/g
- Last potassium > 5.0 mg/dL
- Hypoglycemia episode in past 1 month (glucose < 70 mg/dL)
- Principal investigator discretion (i.e. concerns about safety, compliance)
We found this trial at
2
sites
Geisinger Medical Center Since 1915, Geisinger Medical Center has been known as the region’s resource...
Click here to add this to my saved trials
Click here to add this to my saved trials